Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05149560
What this trial is testing

Ticagrelor Monotherapy After Stenting

Who this might be right for
Acute Myocardial Infarction
Vastra Gotaland Region 200
Testing effectiveness (Phase 2)Study completedNCT03160079
What this trial is testing

Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
University of California, San Diego 16
Early research (Phase 1)Study completedNCT05987696
What this trial is testing

Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

Who this might be right for
AML, AdultMinimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714213
What this trial is testing

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID-19 Condition (PCC or Long COVID)
Christiana Franke 138
Testing effectiveness (Phase 2)Looking for participantsNCT06672146
What this trial is testing

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT02782546
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 60
Not applicableStudy completedNCT02402582
What this trial is testing

Effect of Family-Centered Empowerment Model

Who this might be right for
Acute Myocardial Infarction: Rehabilitation Phase
Baqiyatallah Medical Sciences University 70
Large-scale testing (Phase 3)Study completedNCT02997202
What this trial is testing

A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 356
Testing effectiveness (Phase 2)Ended earlyNCT04240002
What this trial is testing

Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
Astellas Pharma Global Development, Inc. 9
Early research (Phase 1)Ended earlyNCT00313053
What this trial is testing

Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL)
Clare Twist 4
Testing effectiveness (Phase 2)Study completedNCT01035502
What this trial is testing

Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia
Clavis Pharma 51
Testing effectiveness (Phase 2)WithdrawnNCT02520102
What this trial is testing

Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia NOS
Sanofi
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157
What this trial is testing

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more
M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT00875745
What this trial is testing

Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Promyelocytic, AcuteMyelodysplastic Syndromes
Indiana University 15
Early research (Phase 1)Study completedNCT01830777
What this trial is testing

Brentuximab Vedotin + Re-induction Chemotherapy for AML

Who this might be right for
Acute Myelogenous Leukemia
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Study completedNCT02178657
What this trial is testing

Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke

Who this might be right for
Ischemic Stroke
Andalusian Initiative for Advanced Therapies 76
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05826912
What this trial is testing

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
University of California, San Francisco 672
Early research (Phase 1)Study completedNCT02359929
What this trial is testing

BMT Autologous MSCs for GvHD

Who this might be right for
Graft Versus Host DiseaseAcute Graft Versus Host DiseaseChronic Graft Versus Host Disease
Emory University 11
Large-scale testing (Phase 3)Study completedNCT01323153
What this trial is testing

Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Who this might be right for
Coronary Heart Disease
Hoffmann-La Roche 300
Testing effectiveness (Phase 2)Study completedNCT01654445
What this trial is testing

TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion

Who this might be right for
Ischemic Stroke
University of Calgary 50
Next Page